TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
ELTX

Elicio Therapeutics Inc.

Healthcare · Biotechnology

1.50$ -5.0% vs. previous close Closing price · As of: Nov 3, 2026

Ownership

Ownership Structure

Who owns Elicio Therapeutics Inc. (ELTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 70.9% of the shares are freely tradable; institutional investors hold 17.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 17.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 29.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 70.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 9.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 27Mio.

Largest Shareholders

Institutions

Institutions ELTX
Name Stake (%) Shares Change (%) Date
Shah Capital Management 4.61 1,250,000 +0.0 09/30/2026
Knoll Capital Management LP 4.47 1,211,957 +92.1 06/30/2026
BlackRock Inc 2.83 766,005 +1,413.9 06/30/2026
Vanguard Capital Management, LLC 2.11 572,151 +10.3 06/30/2026
Geode Capital Management, LLC 1.15 311,354 +130.4 06/30/2026
State Street Corp 0.66 179,420 +254.4 06/30/2026
Northern Trust Corp 0.48 130,162 +117.9 06/30/2026

Funds

Funds ELTX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.53 415,401 +0.0 09/30/2026
iShares Russell 2000 ETF 1.18 320,377 -1.1 09/30/2026
Fidelity Small Cap Index 0.52 139,731 -0.1 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?